Doris J. Rouse

Expertise

Tuberculosis
International Health
Health Care Access

Biography

As vice president of Global Health at RTI, Dr. Doris Rouse manages the coordination of diverse disciplines to address major global health needs. Currently, she is the project director for two Gates Foundation grants: Venture Investment Technical Assistance to develop new products for global health, and Maternal and Neonatal Directed Assessment of Technology to identify and advance opportunities for improving maternal and neonatal health in low resource settings. Dr. Rouse is the principal investigator for a program funded by the National Institutes of Health to commercialize new treatments for tuberculosis. She has extensive experience in forming public and private consortia, such as the Global Alliance for TB Drug Development. Dr. Rouse serves on the Global Health Advisory Committee for the University of North Carolina School of Public Health. In her tenure as director of the Center for Technology Applications at RTI, she managed technology assessment, outlicensing, and technology sourcing projects for numerous government and corporate clients.

Education

PhD, Physiology and Pharmacology, Duke University; BA, Chemistry, Duke University.

Selected Publications

Ginsberg, A.M., Laurenzi, M.W., Rouse, D.J., Whitney, K.D., & Spigelman, M.K. (Sep 2009). Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy Subjects. Antimicrobial Agents and Chemotherapy, 53 (9):3726-3733.

Ginsberg, A.M., Laurenzi, M.W., Rouse, D.J., Whitney, K.D., & Spigelman, M.K. (Jun 2009). Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects. Antimicrobial Agents and Chemotherapy, 53 (9):3720-3725.

Rouse, D.J., Ejzinga, G., Montagu, D., & Curran, C. (2004). Critical Determinants of Success in the Application of Health Franchising to the Treatment of TB and HIV/AIDS.

Rouse, D.J. (Ed.). (October 2001). Economics of TB Drug Development: New Data for New Research. New York, NY: The Global Alliance for TB Drug Development.

Orme, I., Secrist, J., Anathan, S., Kwong, C., Maddry, J., Reynolds, R., Poffenberger, A., Michael, M., Miller, L., Krahenbuh, J., Adams, L., Biswas, A., Franzblau, S., Rouse, D., Winfield, D., & Brooks, J. (2001). Search for new drugs for treatment of tuberculosis. Antimicrobial Agents and Chemotherapy, 45 (7):1943-1946.

Rouse, D.J. (1996). New competitive realities demand new ways of doing business. Technology Transfer Business Magazine.

Rouse, D.J., Winfield, D.L., & Canada, S.C. (1991 Feb). NASA spinoffs to bioengineering and medicine. Acta Astronautica, 25 (2):103-110.

Rouse, D.J. (1990 Sep). Futurist technology improves care of the elderly. Geriatrics, 45 (9):68-72.

View all publications by Doris J. Rouse…